U.S. Pharmaceuticals & Biotech Breakout Stocks

ICON

Market Cap: US$13.3b

A clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally.

Bio-Techne

Market Cap: US$11.0b

Develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide.

Charles River Laboratories International

Market Cap: US$10.9b

Charles River Laboratories International, Inc.

Definium Therapeutics

Market Cap: US$6.2b

A clinical biopharmaceutical company, develops novel product candidates to treat brain health disorders.

Erasca

Market Cap: US$5.7b

A clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.

Adaptive Biotechnologies

Market Cap: US$3.4b

A commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.

SELLAS Life Sciences Group

Market Cap: US$2.9b

A late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States.

AbCellera Biologics

Market Cap: US$2.5b

Engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States.

Nurix Therapeutics

Market Cap: US$2.5b

A clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases.

Palvella Therapeutics

Market Cap: US$2.2b

A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases.

AtaiBeckley

Market Cap: US$2.0b

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada.

Absci

Market Cap: US$1.9b

A clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States.

Zenas BioPharma

Market Cap: US$1.6b

A clinical-stage biopharma company, engages in the development and commercialization of transformative immunology-based therapies.

ORIC Pharmaceuticals

Market Cap: US$1.1b

A clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms in cancers in the United States.

Achieve Life Sciences

Market Cap: US$639.6m

A late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom.

REGENXBIO

Market Cap: US$618.8m

A clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States.

Contineum Therapeutics

Market Cap: US$560.8m

A clinical stage biopharmaceutical company, engages in developing of small molecules different therapies for neuroscience, inflammation, and immunology indications in the United States.

Myriad Genetics

Market Cap: US$552.5m

A molecular diagnostics and precision medicine company, develops molecular tests.

Pacific Biosciences of California

Market Cap: US$537.3m

Designs, develops, and manufactures sequencing solutions to resolve genetically complex problems.

Silence Therapeutics

Market Cap: US$509.7m

A biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases.

Prelude Therapeutics

Market Cap: US$488.9m

A clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients.

Nika Pharmaceuticals

Market Cap: US$467.0m

Engages in the development and distribution pharmaceutical products for dietary supplements and antiviral drugs in the United States.

Zentalis Pharmaceuticals

Market Cap: US$328.2m

A clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States.

Galectin Therapeutics

Market Cap: US$327.3m

A clinical stage biopharmaceutical company, engages in drug development to create new therapies for fibrotic disease and cancer.

Pyxis Oncology

Market Cap: US$181.2m

A clinical stage company, engages in the development of therapeutics to treat solid tumors.

Rafael Holdings

Market Cap: US$164.3m

Primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and medical devices in the United States and Israel.

ProMIS Neurosciences

Market Cap: US$96.4m

ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada.

EOM Pharmaceuticals Holdings

Market Cap: US$27.8m

A clinical-stage biotechnology company, focuses on the development of drugs to transform therapeutic paradigms and enhance quality of life in patients suffering from debilitating and deadly diseases in the United States.

BetterLife Pharma

Market Cap: US$16.2m

A biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada.

Universe Pharmaceuticals

Market Cap: US$7.9m

Through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China.

Vaccinex

Market Cap: US$2.7m

A clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders.

Cannonau

Market Cap: US$72.5k

Engages in the provision of cannabidiol based products.

Scopus BioPharma

Market Cap: US$25.3k

A clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases with unmet medical needs.